🇺🇸 FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10758613

Combination therapies using anti-metabolites and agents that target tumor-associated strom

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10758614

Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10736919

Materials and methods for engineering cells and uses thereof in immuno-oncology

CRISPR THERAPEUTICS AG · Granted Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10729725

Materials and methods for engineering cells and uses thereof in immuno-oncology

CRISPR THERAPEUTICS AG · Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10730925

Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of

Protalix Ltd. · Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10722537

Activation of resident memory T cells for cancer immunotherapy

Regents of the University of Minnesota · Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10722540

Microfluidic device and method for shear stress-induced transformation of cells

The Regents of the University of California · Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716809

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10702628

Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

Anika Therapeutics S.r.l. · Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10696945

Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem ce

China Medical University · Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10683354

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10675307

Compositions comprising perivascular stem cells and nell-1 protein

The Regents of the University of California · Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10675267

Methods for detection and eradication of myeloid leukemia stem cells

The Regents of the University of California · Granted Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10655103

Equine progenitor cells

University College Cardiff Consultants Limited · Granted Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10633432

VC-CAR molecule and use thereof in removing HIV-1 infected cells

Shenzhen City of Regeneration Biological Pharmaceutical Technology Co., Ltd. · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10633643

Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10633451

Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

Ludwig-Maximilians-Universitat Munchen · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10611998

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o

The Regents of the University of California · Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596275

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to

Aura Biosciences, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583202

Homologous recombination in multipotent adult progenitor cells

Regents of the University of Minnesota · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10583200

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10578608

Tools to detect, track and target cancer cells in vivo

The Regents of the University of California · Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10568913

Method for generating mature β-like cells

Healthregen PTY LTD · Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10564149

Populations of mesenchymal stem cells that secrete neurotrophic factors

BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted